日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Characteristics and predictors of central nervous system relapse in newly diagnosed acute promyelocytic leukemia in the era of arsenic: a 13-year monocenter cohort study

砷剂时代新诊断急性早幼粒细胞白血病中枢神经系统复发的特征和预测因素:一项为期13年的单中心队列研究

Jiang, Bingqian; Tong, Hongyan; Meng, Haitao; Xie, Wanzhuo; Yu, Wenjuan; Huang, Jian; Wang, Huafeng; You, Liangshun; Mao, Liping; Yang, Min; Qian, Jiejing; Ren, Yanling; Yang, Chunmei; Ma, Liya; Jin, Jie; Lou, Yinjun

Blood biomarkers are altered in elderly hematological patients exhibiting a mosaic loss of the Y chromosome in bone marrow cells

老年血液病患者的骨髓细胞中存在Y染色体嵌合性缺失,这些患者的血液生物标志物也随之发生改变。

Liu, Lin; You, Liangshun; Xu, Huan; Wang, Lu; Zhao, Shuqi; Tong, Hongyan; Jin, Jie

Second Cancer Incidence and Cause-Specific Mortality in Primary Gastrointestinal Non-Hodgkin Lymphoma Survivors: A Population-Based Cohort Study

原发性胃肠道非霍奇金淋巴瘤幸存者第二原发癌发生率和特定原因死亡率:一项基于人群的队列研究

Wu, Jiahe; Yang, Jiangping; Ding, Yuxi; Wang, Jili; Cheng, Xiaofei; You, Liangshun; Zhao, Feng

Continuous therapy in HHV-8 negative Multicentric Castleman Disease and prolonged progression-free survival

HHV-8阴性多中心性卡斯尔曼病患者持续治疗可延长无进展生存期

Liu, Yi; Yin, Xuejiao; Ding, Shengnan; Ge, Jiaying; Ma, Liya; Yang, Min; Luo, Xuxia; Zhong, Chengli; Fang, Sishi; Yao, Qiumei; Zhu, Li; Yu, Wenjuan; Mao, Liping; Wei, Juying; Ye, Xingnong; Zhou, De; Tong, Hongyan; Meng, Haitao; Jin, Jie; You, Liangshun

Harnessing Nanotechnology: Emerging Strategies for Multiple Myeloma Therapy

利用纳米技术:多发性骨髓瘤治疗的新兴策略

Yang, Min; Chen, Yu; Zhu, Li; You, Liangshun; Tong, Hongyan; Meng, Haitao; Sheng, Jianpeng; Jin, Jie

When idiopathic multicentric Castleman disease meets COVID-19: a multicenter retrospective study from China

当特发性多中心卡斯尔曼病遇上新冠肺炎:一项来自中国的多中心回顾性研究

Liu, Yi; Yin, Xuejiao; Xu, Dan; Lv, Yunfei; Zhu, Li; Yang, Min; Yao, Qiumei; Jin, Jie; Huang, Li; Meng, Haitao; You, Liangshun

Trends in mortality from infection among patients with hematologic malignancies: differences according to hematologic malignancy subtype

血液系统恶性肿瘤患者感染死亡率趋势:不同血液系统恶性肿瘤亚型之间的差异

Yin, Xuejiao; Hu, Xuelian; Tong, Hongyan; You, Liangshun

Bispecific antibody treatment of multiple myeloma: latest updates from the 2022 ASH annual meeting

双特异性抗体治疗多发性骨髓瘤:2022 年 ASH 年会最新进展

Yin, Xuejiao; Liu, Yi; Sun, Jianai; Tong, Hongyan; Meng, Haitao; You, Liangshun

Bispecific T cell engagers targeting CD20/CD3 in B-cell lymphoma: latest updates from 2023 EHA annual meeting

靶向CD20/CD3的双特异性T细胞衔接器在B细胞淋巴瘤中的应用:2023年欧洲血液学协会年会最新进展

Jin, Shenhe; Liu, Yi; Zhang, Ye; Zhou, Fengping; You, Liangshun; Zhang, Jin

The mechanisms and cross-protection of trained innate immunity

训练有素的先天免疫的机制和交叉保护

Hu, Shiwei; Xiang, Danhong; Zhang, Xinlu; Zhang, Lan; Wang, Shengjie; Jin, Keyi; You, Liangshun; Huang, Jian